Skip to main content
. 2018 Nov 27;120(1):54–56. doi: 10.1038/s41416-018-0342-0

Fig. 1.

Fig. 1

Percent changes of MR parameters and tumour volume after CAR-T treatment for eight lesions in six patients (a). Baseline and follow-up MRSI data was only available for two lesions to compute the percent changes. Changes of progression probabilities (PP) using the predictive model for eight lesions in six patients (b). Changes of PP in 10  recurrent GBM patients without CAR-T therapy (c). The probability of true progression is 50–100% whereas the probability of pseudo-progression is 0–50%